Lightpoint gets CE Mark for Sensei device

By staff writers

January 20, 2021 -- Luminescence imaging technology developer Lightpoint Medical has received a CE Mark for Sensei, the first robotic gamma probe to be commercially available in Europe.

Lightpoint Medical
Lightpoint Medical's Sensei device. Image courtesy of Lightpoint.

Sensei is designed for the intraoperative detection of sentinel lymph nodes and cancer metastasis throughout the lymphatic system. The device aims to provide more precise, targeted cancer surgery and is applicable for major cancer types, including lung, colorectal, stomach, gynecological, and prostate cancer.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking